Mohammed Dawood Alalawy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohammed Dawood Alalawy has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Bhavesh N. Socha
Department of Materials Science, Sardar Patel University, Vallabh Vidyanagar-388120, Gujarat, India
3 shared publications Anju Kunjadiya
Department of Applied and Interdisciplinary Sciences IICISST Sardar Patel University Anand Gujarat India
2 shared publications- Jignesh H. Trivedi
Department of Chemistry Sardar Patel University Vallabh Vidyanagar Gujarat India
2 shared publications - Mohammed Ahmed Al-Salehi
Department of Chemistry Sardar Patel University Vallabh Vidyanagar Gujarat India
2 shared publications Priyanka Dalwadi
Department of Applied and Interdisciplinary Sciences IICISST Sardar Patel University Anand Gujarat India
2 shared publications- Rasmika H. Patel
Sardar Patel University
2 shared publications
Latest Publications
- 3 January 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (1)
Design, Synthesis, and Pharmacological Assessment of Coumarin‐Based Triazole–Phenyl Hybrids: Anticancer, Antioxidant, Antimicrobial, and In Silico Investigations
Two novel libraries of coumarin‐based triazole–phenyl hybrids were efficiently synthesized via a facile, high‐yielding click chemistry approach using a 5‐chloro‐1‐pentyne linker. The synthesized derivatives were characterized by standard spectroscopic and analytical methods and evaluated for anticancer, antioxidant, and antimicrobial activities. The compound bearing a 4‐OCH 3 group ( 5c ) showed the most potent cytotoxicity against A549 lung cancer cells (IC 50 = 17.9 µM), whereas the 4‐F derivative ( 4d ) exhibited the highest antioxidant potential (2,2‐diphenyl‐1‐picrylhydrazyl [DPPH] IC 50 = 93.6 µM). The 4‐Br substituted compound ( 4f ) demonstrated broad‐spectrum antibacterial efficacy, producing the largest inhibition zones against Escherichia coli (13.67 ± 0.49 mm), Pseudomonas aeruginosa (12.33 ± 0.47 mm), Bacillus cereus (12.00 ± 0.58 mm), and Staphylococcus aureus (11.33 ± 0.61 mm). The findings verify a significant correlation between diffusion‐ and dilution‐based assays, supporting their complementary insights into antibacterial effectiveness. Additionally, the 4‐Cl derivative ( 5e ) presented considerable antifungal activity against Aspergillus niger (13.0 ± 0.8 mm). Molecular docking studies of the most active compounds revealed strong interactions with the active sites of their corresponding receptor proteins, exhibiting higher binding affinities than the reference compounds. Absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiling and DFT studies (HOMO–LUMO SSgap: 3.371–4.834 eV) further supported their potential as promising pharmaceutical leads.
- 3 January 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (1)
Design, Synthesis, and Pharmacological Assessment of Coumarin‐Based Triazole–Phenyl Hybrids: Anticancer, Antioxidant, Antimicrobial, and In Silico Investigations
Two novel libraries of coumarin‐based triazole–phenyl hybrids were efficiently synthesized via a facile, high‐yielding click chemistry approach using a 5‐chloro‐1‐pentyne linker. The synthesized derivatives were characterized by standard spectroscopic and analytical methods and evaluated for anticancer, antioxidant, and antimicrobial activities. The compound bearing a 4‐OCH 3 group ( 5c ) showed the most potent cytotoxicity against A549 lung cancer cells (IC 50 = 17.9 µM), whereas the 4‐F derivative ( 4d ) exhibited the highest antioxidant potential (2,2‐diphenyl‐1‐picrylhydrazyl [DPPH] IC 50 = 93.6 µM). The 4‐Br substituted compound ( 4f ) demonstrated broad‐spectrum antibacterial efficacy, producing the largest inhibition zones against Escherichia coli (13.67 ± 0.49 mm), Pseudomonas aeruginosa (12.33 ± 0.47 mm), Bacillus cereus (12.00 ± 0.58 mm), and Staphylococcus aureus (11.33 ± 0.61 mm). The findings verify a significant correlation between diffusion‐ and dilution‐based assays, supporting their complementary insights into antibacterial effectiveness. Additionally, the 4‐Cl derivative ( 5e ) presented considerable antifungal activity against Aspergillus niger (13.0 ± 0.8 mm). Molecular docking studies of the most active compounds revealed strong interactions with the active sites of their corresponding receptor proteins, exhibiting higher binding affinities than the reference compounds. Absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiling and DFT studies (HOMO–LUMO SSgap: 3.371–4.834 eV) further supported their potential as promising pharmaceutical leads.
- 15 January 2022
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1255, 132426
Qualitative and quantitative contributions of intermolecular interactions of dinuclear Ag complexes of sulfathiazole and sulfadiazine: X-ray crystallographic, Hirshfeld surface analysis, DFT studies and biological activities
- 15 January 2022
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1255, 132426
Qualitative and quantitative contributions of intermolecular interactions of dinuclear Ag complexes of sulfathiazole and sulfadiazine: X-ray crystallographic, Hirshfeld surface analysis, DFT studies and biological activities
- 15 October 2021
- Published by Taylor & Francis in Molecular Crystals and Liquid Crystals
- Vol. 732 (1) , 87-101
Synthesis, crystallographic investigation, DFT studies and Hirshfeld surface analysis of novel bromo hydrazine derivative: (E)-2-(2-bromo-4,5-dimethoxybenzilidene)-1-(4,5-dimethoxy-2-methylphenyl)-1-hydroxyhydrazine
A novel bromo hydrazine derivative: (E)-2-(2-bromo-4,5-dimethoxybenzilidene)-1-(4,5-dimethoxy-2-methylphenyl)-1-hydroxyhydrazine is synthesized and characterized by different relevant techniques. The Optical bonding conformed using 1H NMR spectroscopic and Uv-vis studies. The crystallographic data confirmed that the bromo hydrazine derivative crystalizes in monoclinic space group P21/n and consists of bromo dimethoxy phenyl ring and methyl dimethoxy phenyl ring interlinked to each other via hydrazide moiety. The molecular geometry, HOMO-LUMO (frontier molecular orbital) energies, Molecular electrostatic potential (MEP), MPA (Mulliken population analysis), NBO (natural bond orbital), hypercharge polarizability of the title compound has been explored using Density Functional Theory (DFT) calculation via B3LYP method with LAV2P** basis set. Moreover, to visualize the intermolecular interactions and their distribution over the crystal structure, Hirshfeld surfaces and 3D energy framework analyses have been investigated using Crystal Explorer 17.5. In the absence of conventional forces, the weak but collective contribution of C-H…O/N/Br interactions along with direction specific π…π, C-H…π interaction having highest contribution from dispersion energy responsible for molecular stability. Lipophilicity index (log P value) represents significant biological activity of the molecule, correlates well with the contribution of C-H…π interaction. The probable binding modes between title molecule with different active sites of S. aureus (PDB code: 4ALI), E. coli (PDB code: 1QG6), colon cancer (PDB code: 2hq6), lung cancer (PDB code: 1x2j) and 1BNA (DNA) receptors are investigated by molecular docking studies using ArgusLab software.
- 15 October 2021
- Published by Taylor & Francis in Molecular Crystals and Liquid Crystals
- Vol. 732 (1) , 87-101
Synthesis, crystallographic investigation, DFT studies and Hirshfeld surface analysis of novel bromo hydrazine derivative: (E)-2-(2-bromo-4,5-dimethoxybenzilidene)-1-(4,5-dimethoxy-2-methylphenyl)-1-hydroxyhydrazine
A novel bromo hydrazine derivative: (E)-2-(2-bromo-4,5-dimethoxybenzilidene)-1-(4,5-dimethoxy-2-methylphenyl)-1-hydroxyhydrazine is synthesized and characterized by different relevant techniques. The Optical bonding conformed using 1H NMR spectroscopic and Uv-vis studies. The crystallographic data confirmed that the bromo hydrazine derivative crystalizes in monoclinic space group P21/n and consists of bromo dimethoxy phenyl ring and methyl dimethoxy phenyl ring interlinked to each other via hydrazide moiety. The molecular geometry, HOMO-LUMO (frontier molecular orbital) energies, Molecular electrostatic potential (MEP), MPA (Mulliken population analysis), NBO (natural bond orbital), hypercharge polarizability of the title compound has been explored using Density Functional Theory (DFT) calculation via B3LYP method with LAV2P** basis set. Moreover, to visualize the intermolecular interactions and their distribution over the crystal structure, Hirshfeld surfaces and 3D energy framework analyses have been investigated using Crystal Explorer 17.5. In the absence of conventional forces, the weak but collective contribution of C-H…O/N/Br interactions along with direction specific π…π, C-H…π interaction having highest contribution from dispersion energy responsible for molecular stability. Lipophilicity index (log P value) represents significant biological activity of the molecule, correlates well with the contribution of C-H…π interaction. The probable binding modes between title molecule with different active sites of S. aureus (PDB code: 4ALI), E. coli (PDB code: 1QG6), colon cancer (PDB code: 2hq6), lung cancer (PDB code: 1x2j) and 1BNA (DNA) receptors are investigated by molecular docking studies using ArgusLab software.
- 6 October 2021
- Published by Taylor & Francis in Inorganic and Nano-Metal Chemistry
- Vol. 53 (11) , 1259-1267
Lipophilicity, gas-phase optimized geometry, quantum chemical calculations, Hirshfeld surface analysis, energy frameworks, and molecular docking studies of novel (Z)-2-((3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one
The synthesis, optical characterization and crystal structure with biological activity of novel (Z)-2-((3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3,4-dihydronaphthalen 1-(2H)-one (Z2H) has been reported. Crystal structure reports with monoclinic system and space group is P21/c. The extension of this work, stability and reactivity are explored using DFT platform with B3LYP[6-11G(d,p)] basic set. Mulliken charge and HOMO–LUMO energy result indicate that the charge transfer within the molecule. The strong and weak intermolecular interactions of Z2H have been systematically analyzed using Hirshfeld surface analysis. Interaction energy are carried out and indicate that the dispersion energy framework is dominated over the electrostatic energy-frameworks. Lipophilicity index (log P value) represents significant biological activity of the molecules. The molecular docking study confirmed good binding affinity of Z2H with DNA (1BNA), 1h3b and 2p4b. Graphical Abstract
- 6 October 2021
- Published by Taylor & Francis in Inorganic and Nano-Metal Chemistry
- Vol. 53 (11) , 1259-1267
Lipophilicity, gas-phase optimized geometry, quantum chemical calculations, Hirshfeld surface analysis, energy frameworks, and molecular docking studies of novel (Z)-2-((3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one
The synthesis, optical characterization and crystal structure with biological activity of novel (Z)-2-((3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3,4-dihydronaphthalen 1-(2H)-one (Z2H) has been reported. Crystal structure reports with monoclinic system and space group is P21/c. The extension of this work, stability and reactivity are explored using DFT platform with B3LYP[6-11G(d,p)] basic set. Mulliken charge and HOMO–LUMO energy result indicate that the charge transfer within the molecule. The strong and weak intermolecular interactions of Z2H have been systematically analyzed using Hirshfeld surface analysis. Interaction energy are carried out and indicate that the dispersion energy framework is dominated over the electrostatic energy-frameworks. Lipophilicity index (log P value) represents significant biological activity of the molecules. The molecular docking study confirmed good binding affinity of Z2H with DNA (1BNA), 1h3b and 2p4b. Graphical Abstract